{"id":"https://openalex.org/A5116900331","orcid":"https://orcid.org/0009-0004-3997-4360","observed_orcids":["https://orcid.org/0009-0004-3997-4360"],"display_name":"Olanegan Gloria Oluwakemi","raw_author_names":["Olanegan Gloria Oluwakemi","Oluwakemi, Olanegan Gloria"],"full_name":"Olanegan Gloria Oluwakemi","works_count":5,"cited_by_count":41,"summary_stats":{"2yr_mean_citedness":8.2,"h_index":2,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5116900331","orcid":"https://orcid.org/0009-0004-3997-4360","observed_orcids":["https://orcid.org/0009-0004-3997-4360"]},"affiliations":[{"institution":{"id":"https://openalex.org/I134542131","ror":"https://ror.org/032kdwk38","display_name":"University of Ilorin","country_code":"NG","type":"education","lineage":["https://openalex.org/I134542131"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I134542131","ror":"https://ror.org/032kdwk38","display_name":"University of Ilorin","country_code":"NG","type":"education","lineage":["https://openalex.org/I134542131"]}],"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","count":3,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","count":3,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","value":1.94e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13945","display_name":"Legal, Health, Environmental and COVID-19 Challenges","value":1.29e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","value":8.5e-06,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","value":8.2e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11711","display_name":"COVID-19 Pandemic Impacts","value":7.2e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.6962833404541016},{"id":"189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","score":0.48539999127388},{"id":"112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","score":0.4611999988555908},{"id":"138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","score":0.37599998712539673},{"id":"2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","score":0.3467186391353607}],"counts_by_year":[{"year":2025,"works_count":5,"oa_works_count":3,"cited_by_count":41}],"display_name_alternatives":["Olanegan Gloria Oluwakemi","Oluwakemi, Olanegan Gloria"],"block_key":"o oluwakemi","works_api_url":"https://api.openalex.org/works?filter=author.id:A5116900331","updated_date":"2026-10-12T12:34:37","created_date":"2025-10-10T00:00:00"}